Ouhong Wang | OMICS International

Atherosclerosis: Open Access
Open Access

Like us on:

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Ouhong Wang

Amgen Biopharmaceutical Research & Development (Shanghai) Co., Ltd, Shanghai, China. 13F, Building 2, 4560 Jinke Road, Shanghai 201210 P.R. China


Dr. Ouhong Wang  is the member of Amgen Biopharmaceutical Research & Development, China. Dr. Ouhong Wang research activities have been published in high impact journals such as Circulation, the Journal of Pharmaceutical Statistics,  Clinical Journal of the American Society of Nephrology, American Journal of Kidney Diseases, and he has presented his findings at numerous national meetings. Ouhong Wang Skills and Expertise in Osteoporosis and cardiology.

Prevalence and Outcomes of Familial Hypercholesterolemia Patients in a Chinese Myocardial Infarction Cohort

Background and aims: Familial Hypercholesterolemia (FH) is an inherited metabolic disorder with increased LDL-C levels and coronary heart disease (CHD) risk. The prevalence of heterozygous FH is approximately 1:200 to 1:500 worldwide and higher in CHD populations. We aim to estimate the prevalence of FH and the incidence of recurrent cardiovascular... Read More»

Yan Gao, Hong Yin, Ying He, Jihua Wu, Siming Wang, Wenjin Li, Xi Li, Ouhong Wang, Mingqiang Zhang and Lixin Jiang

Research Article: Atheroscler Open Access 2017, 2:114

Abstract Peer-reviewed Full Article Peer-reviewed Article PDF Mobile Full Article